Insider plans sale of 12,348 common shares

An insider of the issuer filed a notice to sell 12,348 shares of common stock under Rule 144.

Accepted by SEC EDGAR 02/04/2026 - 07:40 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

An insider of the issuer filed a notice to sell 12,348 shares of common stock under Rule 144. These shares are to be sold through ETRADE Financial Corporation on NASDAQ, with an aggregate market value of 79,541.32 and 82,569,192 shares of the same class outstanding.

The shares were acquired on 02/04/2026 through settlement of vested restricted stock units as compensation from the issuer. The same person previously sold 4,483 shares for 22,908.13 on 12/03/2025 and 26,535 shares for 170,803.14 on 02/02/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SLDB shares does the insider plan to sell under this Form 144?

The insider plans to sell 12,348 shares of common stock under Rule 144. These shares have an aggregate market value of 79,541.32 and will be sold on NASDAQ through ETRADE Financial Corporation, according to the notice.

How did the insider acquire the 12,348 SLDB shares being sold?

The 12,348 shares were acquired on 02/04/2026 through settlement of vested restricted stock units. The transaction is described as compensation from the issuer, meaning the shares were received as part of the insider’s equity-based pay rather than a cash purchase.

What recent SLDB stock sales has the insider reported before this planned sale?

In the past three months, the insider sold 4,483 shares on 12/03/2025 for 22,908.13 and 26,535 shares on 02/02/2026 for 170,803.14. These prior transactions are listed alongside the newly planned Rule 144 sale.

On which exchange and through which broker will the SLDB shares be sold?

The notice states the common stock will be sold on NASDAQ through ETRADE Financial Corporation, located at 3 Edison Drive, Alpharetta, GA 30005. This identifies both the trading venue and the broker handling the planned Rule 144 sale.

What does the insider represent about non-public information in this SLDB Form 144?

By signing the notice, the insider represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 and the certification language included in the form.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001954826
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Solid Biosciences Inc.
SEC File Number	001-38360
Address of Issuer	500 Rutherford Avenue Charlestown MASSACHUSETTS 02129
Phone	(617)-337-4680
Name of Person for Whose Account the Securities are To Be Sold	Hanrahan Jessie
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	12348	79541.32	82569192	02/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/04/2026	Settlement of vested restricted stock units	Issuer			12348	02/04/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Harahan Jessie 500 Rutherford Avenue Charlestown MA 02129	Common Stock	12/03/2025	4483	22908.13
Harahan Jessie 500 Rutherford Avenue Charlestown MA 02129	Common Stock	02/02/2026	26535	170803.14

144: Remarks and Signature

Remarks	The sale reported on this Form 144 was made to cover witholding taxes following the vesting of previously granted performance stock units pursuant to a durable sale instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-cover-election. The sale does not represent a discretionary trade by Dr. Hanrahan.
Date of Notice	02/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/16/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kimberly Cornwell as attorney-in-fact for Jessie Hanrahan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)